Malignant neoplasms of breast ICD11 code: 2D2Z
Parenteral > General injections > IM: 7.5 mg in prefilled syringe ; 22.5 mg in prefilled syringe
EML status history
Adolescents and adults
Medicines within the same pharmacological class can be used
Patents have expired in most jurisdictions
Read more about patents.
Summary of evidence and Expert Committee recommendations
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, leuprorelin (with a square box) was added to the complementary list of the EML for use in treatment protocols for hormone receptor-positive early stage breast cancer. The relevant extract from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for early stage breast cancer is attached.